Biomark Diagnostics (PK) Stock Quote BMKDF - Stock Price, News, Charts, Message Board, Trades

Register for streaming realtime charts, analysis tools, and prices.

Get Started

Home
Investing
Stocks
USA
USOTC
Biomark Diagnostics Inc (PK) (BMKDF) Quote

Biomark Diagnostics Inc (PK) (BMKDF)

0.22

0.0403

(22.43%)

Closed September 20 4:00PM

Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Current Price

0.22

Bid

0.0945

Ask

0.242

Volume

24,227

0.20355 Day's Range 0.22

0.1335 52 Week Range 0.2303

Market Cap

Previous Close

0.1797

Open

0.22

Last Trade

Last Trade Time

Financial Volume

$ 4,998

VWAP

0.206292

Average Volume (3m)

7,877

Shares Outstanding

90,886,229

Dividend Yield

-

PE Ratio

-14.01

Earnings Per Share (EPS)

-0.02

Revenue

163k

Net Profit

-1.43M

Sector

Medical Laboratories

Industry

Medical Laboratories

Website

www.biomarkdiagnostics.com

Headquarters

Richmond, British Columbia, Can

Founded

-

Biomark Diagnostics Inc (PK) is listed in the Medical Laboratories sector of the OTCMarkets with ticker BMKDF. The last closing price for Biomark Diagnostics (PK) was $0.18. Over the last year, Biomark Diagnostics (PK) shares have traded in a share price range of $ 0.1335 to $ 0.2303.

Biomark Diagnostics (PK) currently has 90,886,229 shares outstanding. The market capitalization of Biomark Diagnostics (PK) is $16.33 million. Biomark Diagnostics (PK) has a price to earnings ratio (PE ratio) of -14.01.

New Cancer Diagnostic Primed to Change the Industry

New Cancer Diagnostic Primed to Change the Industry PR Newswire NEW YORK and VANCOUVER, British Columbia, March 5, 2015 NEW YORK and VANCOUVER, British Columbia, March 5, 2015 /PRNewswire/...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.0112	5.36398467433	0.2088	0.2206	0.17595	21718	0.17974862	CS
4	0.0843	62.1223286662	0.1357	0.2206	0.1335	11795	0.18158738	CS
12	0.0361	19.6302338227	0.1839	0.2206	0.1335	7877	0.17902417	CS
26	0.0065	3.04449648712	0.2135	0.23	0.1335	8332	0.19362016	CS
52	0.015	7.31707317073	0.205	0.2303	0.1335	10331	0.20006878	CS
156	0.077	53.8461538462	0.143	0.253062	0.118	12045	0.18422916	CS
260	0.049	28.6549707602	0.171	0.5083	0.0824	15528	0.23683045	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
JUVAFJuva Life Inc (CE)	$ 0.002 (199,900.00%)	15.5k
BLSTFBlackstone Minerals Ltd (PK)	$ 0.0271 (27,000.00%)	30k
TLSSTransportation and Logistics Systems Inc (CE)	$ 0.0001 (9,900.00%)	3.1M
GOSYGeckosystems International Corp (CE)	$ 0.0001 (9,900.00%)	1.15M
MMEXMMEX Resources Corporation (PK)	$ 0.0001 (9,900.00%)	745.41k
TEVNFTevano Systems Holdings Inc (CE)	$ 0.000001 (-99.99%)	10k
SNSTSunset Capital Assets Omc (CE)	$ 0.000001 (-99.99%)	85.03k
PNDDFPender Growth Fund Inc (PK)	$ 0.0012 (-99.98%)	100
HLLPFHello Pal International Inc (CE)	$ 0.000001 (-99.90%)	5k
ELOXEloxx Pharmaceuticals Inc (CE)	$ 0.000001 (-99.83%)	297
IMTLImage Protect Inc (PK)	$ 0.0002 (100.00%)	591.38M
TMGIMarquie Group Inc (PK)	$ 0.0001 (0.00%)	244.01M
SINCSincerity Applied Materials Holdings Corporation (PK)	$ 0.001 (42.86%)	214.48M
SIRCSolar Integrated Roofing Corporation (PK)	$ 0.0002 (0.00%)	167.08M
HMBLHUMBL Inc (PK)	$ 0.0001 (-33.33%)	118.85M

MERCURIAL

MERCURIAL 4 years ago

I hear you. Loading :)

MADDSTACKER

MADDSTACKER 4 years ago

Covid and lung cancer screening this going to dollars imho ...

MADDSTACKER

MADDSTACKER 4 years ago

I’m so alone .. can anyone hear me .. bawhahahaha

MADDSTACKER

MADDSTACKER 4 years ago

Covid test kits , in talks with government ,, 2 weeks expect a roll out ....

STOCKPICKER4LIFE

STOCKPICKER4LIFE 7 years ago

ronpopeil

ronpopeil 8 years ago

Does anyone follow this company anymore?

Bing420

Bing420 8 years ago

Soooo...any reason for the tanking in the last day?

MichaelVest

MichaelVest 8 years ago

BioMark raw data collection complete on 200 patient trial. Data will be reviewed then compiled into a report. Trial met both Health Canada and U.S. FDA standards.

Complete article below:

Data Collection

MichaelVest

MichaelVest 8 years ago

Expect commercializing of BioMark's early detection red alert technology. Looking like 2016 will be a big year for BioMark!!!

MichaelVest

MichaelVest 8 years ago

BioMark receives approval from Health Canada and the Ethics Review Board for their lung cancer protocol, and will now start pilot study at CancerCare Manitoba in April.

Full article here: Lung Cancer Protocol

MichaelVest

MichaelVest 9 years ago

Great Video BioMark Cancer Survivorship Program

Cancer Survivorship Program

MichaelVest

MichaelVest 9 years ago

A good article regarding BioMark

A Good Choice For MMJ and Biotech Market Opportunity

MichaelVest

MichaelVest 9 years ago

BioMark Announces Progress

[url][/url][tag]Progress with Assayhttp://www.biomarkdiagnostics.com/investor-relations/investment-highlights/news-releases/[/tag]

MichaelVest

MichaelVest 9 years ago

Quest for Game Changing Lung Cancer Diagnostic Assay Video

MichaelVest

MichaelVest 9 years ago

BioMark expects to begin study of its' assay in 4th quarter of 2015

Begin assay study in 4th quarter

MichaelVest

MichaelVest 9 years ago

BioMark receives clearance from Health Canada to commence clinical trial of their assay.

Health Canada clearance

MichaelVest

MichaelVest 9 years ago

Interim financial report June 2015

Fin. report

MichaelVest

MichaelVest 9 years ago

Dr. Thomas Malcolm to head U.S. operations. Brings experience to U.S. strategy.

Ph.D in molecular biology and biochemistry, and a post doctoral fellow for both Mount Sinai School of Medicine and Memorial Sloan Kettering Cancer Center.

MichaelVest

MichaelVest 9 years ago

BioMark lays out plan for U.S.

Going to be based in Maryland, appointed head of U.S. operations, planning on gaining approval from Health Canada in 2016, then FDA approval to follow.

U.S. Strategy

MichaelVest

MichaelVest 9 years ago

BioMark is four weeks out with data on their assay cancer test. Look to be meeting all requirements for FDA.

Press release here

MichaelVest

MichaelVest 9 years ago

Two patent applications for BioMark below:

Monoclonal Antibody

and

Method for Assaying

MichaelVest

MichaelVest 9 years ago

Company currently holds patent for their tech. Patent number 6811967 Link below for full patent information:

Full patent info

MichaelVest

MichaelVest 9 years ago

From Nov. 2014 but good information on what the company is trying to do.

BioMark Diagnostics Info

GoBison

GoBison 10 years ago

Anyone trading this yet?

jupp

jupp 10 years ago

BioMark Announces Grant Funded Partnership With TMIC

www.fscwire.com/newsrelease/biomark-announces-grant-funded-partnership-tmic

BioMark Brings New Life to Cancer Detection Technology

www.biomarkdiagnostics.com/biomark-brings-new-life-to-cancer-detection-technology/

BioMark Announces Private Placement

www.fscwire.com/newsrelease/biomark-announces-private-placement

Biomark Diagnostics (PK)

Delayed Upgrade Clock